Sanofi did combine lixisenatide with insulin glargine in a premixed pen (Soliqua), which was a novel combo product for patients needing both basal insulin and a GLP-1 RA
Additional studies are still underway, including TRIUMPH-2, which focuses on obesity with type 2 diabetes, and TRIUMPH-3, which is evaluating retatrutide in people with obesity and cardiovascular disease
Comprehensive Weight Loss Treatments for Women Over 40 Women over 40 face unique challenges when it comes to weight management, often influenced by hormonal changes, menopause, and slowing metabolism
The initial consultation is the first step, theres no commitment to a full program before your physician completes your evaluation and confirms eligibility
However, patients should inform their healthcare provider about creatine use to ensure appropriate kidney function monitoring and hydration management